Daewoong Pharma licenses AI-discovered IBD drug from Korea's Innovo (Chosun Biz) - May 14, 2026 - "With this agreement, Daewoong Pharmaceutical secured exclusive worldwide rights to develop, manufacture, and commercialize INV-008"
Licensing / partnership • Inflammatory Bowel Disease
|